Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-404-7 | CAS number: 106-50-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Oral Minimum Lethal Dose (rat gavage) = 75 mg/kg
Dermal Weight of Evidence indicates that the test substance did not produce mortality in experimental animals (guinea pigs and rabbits)
Inhalation 4-hour LC50 (rats) = -0.92 mg/L
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- discriminating dose
- Value:
- 75 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 920 mg/m³ air
Additional information
Acute Oral Toxicity: The test substance has an acute oral minimum lethal dose in rats of 75 mg/kg. After administration to 50 mg/kg and above, acute toxicity was associated with central nervous system effects, observed as unsteady gait, loss of balance, lateral decubitus, piloerection, and/or tremors. In addition, rhabdomyolysis was observed in mice and humans at an oral dose level around or below 80 m/kg.
Acute Inhalation Toxicity: The test substance is moderately toxic via the inhalation route with a 4-hour LC50 of 0.92 mg/L (920 mg/m3). After inhalation to the substance at ≥0.94 mg/L (≥940 mg/m3), acute toxicity was associated with central nervous system effects observed as no righting reflex and tremors.
Acute Dermal Toxicity: The test substance was applied to New Zealand Albino rabbits as a 40% aqueous solution suspension for a period of 24 hours at doses of 5010 and 7940 mg/kg. All animals dosed (one female in the 5010 mg/kg group and one male and female in the 7940 mg/kg group) survived the 14 day observation period. Weight loss was observed 2-4 days following dosing. The LD50 was > 7940 mg/kg (Y-78-192- Monsanto). A 10% concentration of test substance was applied to shaved, intact skin of 3 rabbits (sex not reported). Under the conditions of this study, the test substance in dry form or 10% alcohol applied to the shaved, intact skin of rabbits produced no systemic toxicity. Moderate erythema was observed with the 10% alcoholic solution. No mortality was observed (Hanzlik, 1923). Guinea pigs were treated dermally with the test substance (99% purity) for 15 or 30 days. The amount applied was 0.1 mL with a concentration of 3% solution in 25% ethanol. After 15 days of treatment, 5 animals of the control and 5 animals of the test group were sacrificed. After 30 days of treatment, the same process was repeated. No mortality was reported (Mathur et al., 1992). Guinea pigs were exposed dermally (2 x 2 cm clipped area) to the test substance for 30 days. The animals were treated (12 animals each in treatment and control groups) with 4 mg/kg of 1% solution of the test substance in 25% ethanol. No morality was reported (Mathur et al., 2005). While each of the studies described alone would be insufficient to completely describe the potential dermal toxicity of the test substance, they each demonstrate that dermal application of test substance did not produce mortality in experimental animals (guinea pigs and rabbits). In addition, although the number of animals used is low (n=3) as reported in the Y-78-192 study, the doses of test material were not trivial (> 5000 mg/kg). The weight of evidence indicates that test substance is not considered toxic via the dermal route of exposure.
Justification for classification or non-classification
Based on the acute minimum lethal dose in the rat (75 mg/kg) and the 4-hour inhalation LC50 in the rat (920 mg/m3), the substance should classified as T; R 23/25: Toxic, Toxic by inhalation and if swallowed for acute toxicity according the EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008. While each of the dermal studies described alone would be insufficient to completely describe the potential dermal toxicity of the test substance, they each demonstrate that dermal application of test substance did not produce mortality in experimental animals (guinea pigs and rabbits). In addition, although the number of animals used is low (n=3) as reported in the Y-78-192 study, the dose of test material were not trivial (> 5000 mg/kg). The weight of evidence indicates that test substance is not considered toxic via the dermal route of exposure. Although the current information in this IUCLID on the substance would indicate a minor deviation from the harmonised classification (R24), the harmonised classification will be adhered as it is stricter. Therefore, the test substance will be classified as R23/24/25, Toxic; by inhalation, in contact with skin and if swallowed according the EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
